Relative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy.
AffiliationDepartment of Clinical Oncology and Radiotherapy, Christie Hospital and Holt Radium Institute, Withington, Manchester, England.
MetadataShow full item record
AbstractA study was made of 242 cases of T2 No glottic cancer treated by definitive radiotherapy over a 15-year period. The aim was to examine the relative influences of tumor biological dose (indicated by locoregional control) versus dose per fraction on the occurrence of late normal tissue effects; in addition, the impact of cord mobility on outcome was analyzed. The 5-year survival corrected for intercurrent deaths was 84% and local disease-free (larynx and/or nodes) survival was 76%. Using Cox regression analysis the only factor significant for local control was cord mobility (p < 0.0001) which also had an effect on overall survival (p < 0.0001); subdivision of T2 glottic staging should be reintroduced into staging classifications. It is evident that comparison of clinical results between centers is potentially prejudiced by an array of factors relating not only to fractionation differences but also variation in clinical and organizational aspects of care. Nevertheless, using other published data for comparison, it seems likely that the serious morbidity rate of 4.1% seen in this study is due in some part to the high tumor biological dose (resulting in high local control). The influence of fraction size was difficult to discern as equivalence in local control was not seen in the data chosen.
CitationRelative clinical influence of tumor dose versus dose per fraction on the occurrence of late normal tissue morbidity following larynx radiotherapy. 1993, 25 (1):23-8 Int. J. Radiat. Oncol. Biol. Phys.
JournalInternational Journal of Radiation Oncology, Biology, Physics
- Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
- Authors: Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL
- Issue date: 1997 Aug 1
- Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
- Authors: Fein DA, Lee WR, Hanlon AL, Ridge JA, Curran WJ, Coia LR
- Issue date: 1996 Mar 1
- T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
- Authors: Fein DA, Mendenhall WM, Parsons JT, Million RR
- Issue date: 1993 Mar 15
- Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
- Authors: Franchin G, Minatel E, Gobitti C, Talamini R, Vaccher E, Sartor G, Politi D, Trovò MG, Barzan L
- Issue date: 2003 Aug 15
- Radiotherapy of early-stage glottic cancer: analysis of factors affecting prognosis.
- Authors: Chen MF, Chang JT, Tsang NM, Liao CT, Chen WC
- Issue date: 2003 Oct